Cortisol Control
Cortisol Control, licence 80090058: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Cognitive Control, Para Restore, ParaEase, Stress & Sleep Aid, Stress Assist, Stress Control, Stress Escape, Stress Release, Stress Rest
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80090058
- Status
- Active licence
- Licence date
- 10 January 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Withania somnifera Source : Feuille Extraction ratio : 8:1 Dry plant equivalent : 1600 mg Potency : 8.0 % Withanolides | 200.0 mg | Not calculated |
| Withania somnifera Source : Feuille Potency : 32.0 % Withania oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Feuille Potency : 2.0 % Withaferin A | Not specified | Not calculated |
| Withania somnifera Source : Racine Extraction ratio : 8:1 Dry plant equivalent : 1600 mg Potency : 8.0 % Withanolides | 200.0 mg | Not calculated |
| Withania somnifera Source : Racine Potency : 32.0 % Withania oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Racine Potency : 2.0 % Withaferin A | Not specified | Not calculated |
| L-théanine Source : L-Théanine | 200.0 mg | Not calculated |
| Phosphatidylsérine Source : Phosphatidylserine | 300.0 mg | Not calculated |
| Magnolia officinalis Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 7.0:1.0 Dry plant equivalent : 1050.0 mg | 150.0 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate. Helps reduce cortisol and C-reactive protein levels, the biomarkers of physical stress. Helps to temporarily promote relaxation. Helps to support cognitive function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80090058
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.